{
     "PMID": "24080178",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20140825",
     "LR": "20161125",
     "IS": "1558-1497 (Electronic) 0197-4580 (Linking)",
     "VI": "35",
     "IP": "2",
     "DP": "2014 Feb",
     "TI": "Hippocampal and cortical atrophy in amyloid-negative mild cognitive impairments: comparison with amyloid-positive mild cognitive impairment.",
     "PG": "291-300",
     "LID": "10.1016/j.neurobiolaging.2013.08.017 [doi] S0197-4580(13)00351-5 [pii]",
     "AB": "Although patients with amnestic mild cognitive impairment (aMCI) are at higher risk of developing Alzheimer's disease (AD), their pathologies could be heterogeneous. We aimed to evaluate structural changes in amyloid-negative and amyloid-positive aMCI patients. Forty-eight aMCI patients who underwent Pittsburgh compound B (PiB) positron emission tomography were recruited. They were classified as PiB (-) aMCI (N = 16) and PiB (+) (N = 32). Hippocampal shape and regional cortical thickness were compared with 41 subjects with normal cognition (NC). Relative to NC, PiB(-) aMCI exhibited hippocampal deformity in the right cornu ammonis 1, whereas PiB(+) aMCI exhibited hippocampal deformity in bilateral subiculum and cornu ammonis 1 subregions. Relative to NC, PiB(-) aMCI showed cortical thinning in the left medial prefrontal and right anterior temporal regions, whereas PiB(+) aMCI exhibited cortical thinning in bilateral medial temporal regions, temporoparietal junctions and precuneus, and prefrontal cortices. Our findings suggest that structural changes in PiB(-) aMCI might be due to several possible pathologic changes, whereas structural changes in PiB(+) aMCI reflect AD-like structural changes.",
     "CI": [
          "Copyright (c) 2014 Elsevier Inc. All rights reserved."
     ],
     "FAU": [
          "Ye, Byoung Seok",
          "Seo, Sang Won",
          "Kim, Chi Hun",
          "Jeon, Seun",
          "Kim, Geon Ha",
          "Noh, Young",
          "Cho, Hanna",
          "Yoon, Cindy W",
          "Kim, Hee Jin",
          "Jang, Eun Young",
          "Lee, Jeongmin",
          "Kim, Jung-Hyun",
          "Chin, Juhee",
          "Lee, Jong Min",
          "Kim, Jeong-Hun",
          "Seong, Joon-kyung",
          "Kim, Chang-Hun",
          "Choe, Yearn Seong",
          "Lee, Kyung Han",
          "Na, Duk L"
     ],
     "AU": [
          "Ye BS",
          "Seo SW",
          "Kim CH",
          "Jeon S",
          "Kim GH",
          "Noh Y",
          "Cho H",
          "Yoon CW",
          "Kim HJ",
          "Jang EY",
          "Lee J",
          "Kim JH",
          "Chin J",
          "Lee JM",
          "Kim JH",
          "Seong JK",
          "Kim CH",
          "Choe YS",
          "Lee KH",
          "Na DL"
     ],
     "AD": "Department of Neurology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Comparative Study",
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20130927",
     "PL": "United States",
     "TA": "Neurobiol Aging",
     "JT": "Neurobiology of aging",
     "JID": "8100437",
     "RN": [
          "0 (2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole)",
          "0 (Amyloid)",
          "0 (Aniline Compounds)",
          "0 (Radiopharmaceuticals)",
          "0 (Thiazoles)"
     ],
     "SB": "IM",
     "MH": [
          "Aged",
          "Aged, 80 and over",
          "Alzheimer Disease",
          "Amyloid/*metabolism",
          "Aniline Compounds",
          "Atrophy",
          "Cerebral Cortex/diagnostic imaging/metabolism/*pathology",
          "Cognitive Dysfunction/diagnostic imaging/*metabolism/*pathology",
          "Female",
          "Hippocampus/diagnostic imaging/metabolism/*pathology",
          "Humans",
          "Magnetic Resonance Imaging",
          "Male",
          "Middle Aged",
          "Neuropsychological Tests",
          "Positron-Emission Tomography",
          "Prospective Studies",
          "Radiopharmaceuticals",
          "Risk",
          "Thiazoles"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Alzheimer's disease",
          "Cortical thickness",
          "Hippocampus",
          "Mild cognitive impairment",
          "Pittsburgh compound B"
     ],
     "EDAT": "2013/10/02 06:00",
     "MHDA": "2014/08/26 06:00",
     "CRDT": [
          "2013/10/02 06:00"
     ],
     "PHST": [
          "2013/03/22 00:00 [received]",
          "2013/08/05 00:00 [revised]",
          "2013/08/16 00:00 [accepted]",
          "2013/10/02 06:00 [entrez]",
          "2013/10/02 06:00 [pubmed]",
          "2014/08/26 06:00 [medline]"
     ],
     "AID": [
          "S0197-4580(13)00351-5 [pii]",
          "10.1016/j.neurobiolaging.2013.08.017 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neurobiol Aging. 2014 Feb;35(2):291-300. doi: 10.1016/j.neurobiolaging.2013.08.017. Epub 2013 Sep 27.",
     "term": "hippocampus"
}